Search

Your search keyword '"James Robert Brašić"' showing total 164 results

Search Constraints

Start Over You searched for: Author "James Robert Brašić" Remove constraint Author: "James Robert Brašić"
164 results on '"James Robert Brašić"'

Search Results

1. Optimal Antithrombotic Regimen After Cryptogenic Stroke: A Systematic Review and Network Meta-Analysis

2. The Efficacy of Medical Interventions for Free-Floating Thrombus in Cerebrovascular Events: A Systematic Review

3. Feasibility of virtual low-cost quantitative continuous measurement of movements in the extremities of people with Parkinson’s disease

5. Dataset of quality assurance measurements of rhythmic movements

6. Oncolytic Viral Therapy with Gravity Approaching Zero to Ameliorate Glioblastoma Multiforme

7. Istaroxime for Patients with Acute Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

8. A Deep Learning Approach for Automatic and Objective Grading of the Motor Impairment Severity in Parkinson’s Disease for Use in Tele-Assessments

9. Contact Force-Guided versus Contact Force-Blinded Cavo-Tricuspid Isthmus Ablation for Atrial Flutter: A Systematic Review and Meta-Analysis

10. Amelioration of Glioblastoma Multiforme via the Combination of Simulated Microgravity and Oncolytic Viral Therapy

11. Classification of extremity movements by visual observation of signals and their transforms

12. Tic Reduction Following Heat-Induced Dehydration in Gilles de la Tourette Syndrome (TS)

13. The role of lumateperone in the treatment of schizophrenia

15. Dataset of quantitative structured office measurements of movements in the extremities

16. A low-cost quantitative continuous measurement of movements in the extremities of people with Parkinson's disease

17. Nuclear neurotransmitter molecular imaging of autism spectrum disorder

18. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

19. Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study

20. Precision medicine to identify optimal diagnostic and therapeutic interventions for Parkinson's Disease

21. Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for

22. An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants

23. The Effect of Vitamin D Supplementation on the Severity of Symptoms and the Quality of Life in Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

24. Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study

26. An evaluation of lumateperone tosylate for the treatment of schizophrenia

27. The Efficacy and Safety of Direct Oral Anticoagulants versus Standard of Care in Patients without an Indication of Anti-Coagulants after Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

28. The role of lumateperone in the treatment of schizophrenia

29. Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study

30. Molecular Imaging of the Serotonin Transporter Availability and Occupancy by Antidepressant Treatment in Late-Life Depression

31. Differentiation of Zaghrouta, Ululation to Express Joy in the Middle East, from Movement Disorders and Other Conditions

32. Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome

33. Molecular imaging of beta-amyloid deposition in late-life depression

34. The Courage to Prevail

35. Nuclear neurotransmitter molecular imaging of autism spectrum disorder

36. Dataset of quantitative structured office measurements of movements in the extremities

37. Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

38. Metabotropic glutamate receptor 5 tracer [18F]-FPEB displays increased binding potential in postcentral gyrus and cerebellum of male individuals with autism: a pilot PET study

39. Molecular imaging of autism spectrum disorder

40. Linking dopaminergic reward signals to the development of attentional bias: A positron emission tomographic study

41. Beta-amyloid (Aβ) uptake by PET imaging in older HIV+ and HIV- individuals

42. The Urgent Need for Molecular Imaging to Confirm Target Engagement for Clinical Trials of Fragile X Syndrome and Other Subtypes of Autism Spectrum Disorder

43. Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants

44. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease

45. A low-cost quantitative continuous measurement of movements in the extremities of people with Parkinson's disease

46. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948

47. The Role of Dopamine in Value-Based Attentional Orienting

48. GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding

49. Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use

50. Characterization of 3 Novel Tau Radiopharmaceuticals

Catalog

Books, media, physical & digital resources